SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-18-064175
Filing Date
2018-10-26
Accepted
2018-10-26 16:27:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D a18-37213_1sc13d.htm SC 13D 66031
  Complete submission text file 0001104659-18-064175.txt   67313
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Filed by) CIK: 0001291961 (see all company filings)

Type: SC 13D

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Subject) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88731 | Film No.: 181141896
SIC: 2834 Pharmaceutical Preparations